Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14287513 | 0.93 | LMNA (0.53) | LMNATSHRTDP1SLC6A3MAPK1 | |
| SCHEMBL11358478 | 0.93 | LMNA (0.53) | LMNATSHRTDP1SLC6A3MAPK1 | |
| P-Xylene SCHEMBL28048503 | 0.93 | NPC1 (0.63) | LMNATSHRTDP1SLC6A3MAPK1 | |
| SCHEMBL29104383 | 0.89 | TDP1 (0.66) | LMNATSHRTDP1SLC6A3MAPK1 | |
| SCHEMBL14898425 | 0.89 | ESR1 (0.52) | LMNATSHRTDP1MAPK1SLC6A2 | |
| SCHEMBL27914437 | 0.89 | KDM4E (0.60) | LMNATSHRTDP1KMT2AALDH1A1 | |
| SCHEMBL28875175 | 0.87 | TDP1 (0.68) | LMNATSHRTDP1SLC6A3MAPK1 | |
| SCHEMBL51601 | 0.87 | TDP1 (0.68) | LMNATSHRTDP1SLC6A3MAPK1 | |
| SCHEMBL15397149 | 0.86 | MAPT (0.54) | LMNATSHRTDP1SLC6A2ALDH1A1 | |
| SCHEMBL27796834 | 0.83 | LMNA (0.61) | LMNATSHRTDP1SLC6A3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3375883-B1 | METHOD FOR PRODUCING N EPSILON -ACYL-L-LYSINE | AJINOMOTO KK (JP) | 2021-02-03 | — | — | EP | claimed |
| US-10266857-B2 | Method for producing Nε-acyl-L-lysine | AJINOMOTO CO., INC. (JP) | 2019-04-23 | — | — | US | claimed |
| EP-3375883-A1 | METHOD FOR PRODUCING N EPSILON -ACYL-L-LYSINE | Ajinomoto Co., Inc. (JP) | 2018-09-19 | — | — | EP | claimed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| US-20230293569-A1 | MODULATING NUDIX HOMOLOGY DOMAIN (NHD) WITH NICOTINAMIDE MONONUCLEOTIDE ANALOGS AND DERIVATIVES OF SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2023-09-21 | — | — | US | disclosed |
| US-20230158053-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES | METROBIOTECH, LLC | 2023-05-25 | — | — | US | disclosed |
| US-20230125751-A1 | METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS | GILEAD SCIENCES, INC. | 2023-04-27 | — | — | US | disclosed |
| WO-2023066359-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY | LHOTSE BIO, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| EP-3375883-B1 | METHOD FOR PRODUCING N EPSILON -ACYL-L-LYSINE | AJINOMOTO KK (JP) | 2021-02-03 | — | — | EP | disclosed |
| WO-2020011147-A1 | RORγ ANTAGONIST AND APPLICATION THEREOF IN MEDICINE | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2020-01-16 | — | — | WO | disclosed |
| US-20070049696-A1 | Reacting a acrylic and vinyl monomer in presence of free radical catalyst | CID CENTRO DE INVESTIGACION Y DESARROLLO TECNOLOGICO SA DE CV (MX) | 2007-03-01 | — | — | US | disclosed |
| CN-1128783-C | Process for distillation of crude ester in DMT/PTA process | DEGUSSA (DE) | 2003-11-26 | — | — | CN | disclosed |
| CN-1106385-C | Substituted 4-benzoyl-pyrazoles | BASF AG (DE) | 2003-04-23 | — | — | CN | disclosed |
| WO-2002068417-A3 | HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | SLASSI ABDELMALIK (CA) | 2002-11-14 | — | — | WO | disclosed |
| CN-1247532-A | Substituted 4-benzoylpyrazoles | BASF AG (DE) | 2000-03-15 | — | — | CN | disclosed |
| CN-1245488-A | Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect | BASF AG (DE) | 2000-02-23 | — | — | CN | disclosed |
| US-5859143-A | BLOCK COPOLYMERIZATION REACTION IN PRESENCE OF HYDROGEN AND STEREOSPECIFIC CATALYST CONTAINING COMPOUNDS OF MAGNESIUM, TITANIUM, HALOGEN, ORGANOALUMINUM AND ELECTRON DONOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-01-12 | — | — | US | disclosed |
| CN-1176847-A | Catalyst and method for catalytic off-gas cleaning in DMT process | HUELS CHEMISCHE WERKE AG (DE) | 1998-03-25 | — | — | CN | disclosed |
| CN-1172101-A | Process for distillation of crude ester in DMT/PTA process | HUELS CHEMISCHE WERKE AG (DE) | 1998-02-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158053-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES | NAMPT, NNT, NQO1 | LMNA 603/4885TSHR 3861/4885TDP1 2917/4885 |
| US-20230125751-A1 | METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS | PNP, RPIA, HPRT1 | LMNA 1211/4885TSHR 3767/4885TDP1 298/4885 |
| US-20230293569-A1 | MODULATING NUDIX HOMOLOGY DOMAIN (NHD) WITH NICOTINAMIDE MONONUCLEOTIDE ANALOGS AND DERIVATIVES OF SAME | NAMPT, NUDT15, NME4 | LMNA 787/4885TSHR 3809/4885TDP1 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.